F-star Therapeutics Inc. Recorded Big Gain

Fri, Dec 30, 2022 at 07:06 PM

F-star Therapeutics Inc. (FSTX:NASDAQ) soared at $6.32, a gain of 54.5%. The stock appeared on our News Catalysts scanner on Tue, Dec 06, 2022 at 06:44 AM in the 'BIOTECH' category. From Fri, Dec 16, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

The stock spiked on Wed, Dec 28, 2022 at $6.93 with a volume of 1M+.

About F-star Therapeutics Inc. (FSTX:NASDAQ)

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy.

Top 10 Gainers:

Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
Palisade Bio Inc. (PALI:NASDAQ), 61.49%
F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%